Metrovision announces its entry into the US market with the MonCvONE line of perimeters.
SRD Vision, LLC Philadelphia will be the US distributor for Metrovision's products.
New techniques for the evaluation of diseases of the retinaDiscover
Click here to contact usInformations
METROVISION's products are manufactured under the most stringent quality control conditionsCertifications
Metrovision is pleased to announce its new model of visual field perimeter, MonCvONE-CR. This concentrate of innovative technology is addressing clinical research centers and is already used by internationaly renowned centers such as the National Eye Institute in USA, the University of Sydney, the University of Nantes ...
MonCvONE-CR is the only visual field perimeter allowing the evaluation of diurnal vision (photopic) as well as nocturnal (scotopic) and crepuscular (mesopic).
Numerous recent studies show that the evaluation of crepuscular vision can be of particular interest for the early detection of pathologies of the retina..Discover MonCvONE-CR →
Training seminar for Vision Monitor users (in English)Click here to register
Séminaire des utilisateurs du Moniteur Ophtalmologique (Français)Cliquer ici pour le formulaire d'inscription
ARVO Association for Research in Vision and Ophthalmology
ISCEV 2018 International Society of Clinical Electrophysiology of Vision
SFO 2018 French Society of Ophthalmology
NeuroVision Consulting has equipped 2 medical centers in Geneva and Los Angeles with Metrovision systems for eye-tracking to study the exploratory visual strategy, contrast perception and discomfort glare. The 2 systems are currently used for sport and human performance training.Read more
A study performed by the Psychotherapy research group of Nancy University Medical Center demonstrates a delay in pattern ERG responses in regular cannabis users. These findings "may be important from a public health perspective since they could highlight the neurotoxic effects of cannabis use on the central nervous system as a result of how it affects retinal processing." This study was performed on the Vision Monitor MonpackONE system and published in JAMA Ophthalmology.Read more
with more than one hundred systems installed in China, Korea, India, Indonasia, Vietnam, Thailand and Malaisia, Metrovision continues its development in Asia.